New Gradipore CEO makes his mark with restructure
04 July, 2002 by Iain ScottThe new US-based CEO of bioseparations specialist Gradipore has wasted no time in making his mark on the company, announcing changes to its management structure during a visit to Australia.
Autogen stocks soar as Gutnick sells out
03 July, 2002 by Tanya HollisMining magnate Joseph Gutnick has relinquished his stake in Autogen in a move that allows the gene discovery company a more complete biotech focus.
Rathjen nets top job at Adelaide science faculty
02 July, 2002 by Melissa TrudingerLeading stem cell scientist Prof Peter Rathjen has been appointed executive dean of the new Faculty of Sciences at the University of Adelaide.
Iatia's technology wins R&D 100 Award
02 July, 2002 by Tanya HollisMelbourne vision sciences company Iatia has taken out the top award for optical imaging technology in a prestigious international competition.
McComas steps down from EpiTan board
02 July, 2002 by Tanya HollisInvestment banker Malcolm McComas has resigned from the board of Melbourne tanning drug company EpiTan after almost three years.
Victorian TAFE to offer biotech degrees
01 July, 2002 by Tanya HollisBiotechnology will be among a raft of specialised degrees on offer at Victorian TAFE institutes.
Industry R&D spending shows first rise in four years
01 July, 2002 by Iain ScottBusiness expenditure on R&D (BERD) in 2000-01 increased for the first time in four years, according to Australian Bureau of Statistics data released today.
CSIRO appointments indicate greater biotech role
01 July, 2002 by Pete YoungThe arrival of a group of new appointees on the board of CSIRO could foreshadow a larger role for biotechnology within Australia's premier scientific research organisation.
Bio21 foreshadows new collaborations
01 July, 2002 by Tanya HollisMelbourne's Bio21 precinct is starting to make new waves, with at least three potential collaborations currently on the boil.
Concern over US plan to push up patent fees
28 June, 2002 by Pete YoungA push for higher fees by the US Patent and Trademark Office (PTO) could spell trouble for small Australian biotechs and technology transfer companies.
Grant money comes through for research facilities
28 June, 2002 by Pete YoungAfter nine months of confusion and frustration, 15 major research facilities appear poised to enjoy the benefits of a five-year, $150 million Federal Government grant scheme.
IDT finalises trials facility purchase
27 June, 2002 by Tanya HollisMelbourne-based contract research and drug manufacturing company Institute of Drug Technology Australia (ASX: IDT) has finalised its purchase of a human clinical trials facility in Adelaide.
US bio-IT outfit Tripos sets up shop in Aust
27 June, 2002 by Pete YoungUS bioinformatics software and discovery research company Tripos has reacted to the expanding Australian life science sector by setting up a direct presence here for the first time.
Monash appoints new synchro chair
26 June, 2002 by Tanya HollisMonash University has appointed Australia's first Professor of X-ray and Synchrotron Physics to build a research base for the National Synchrotron Project.
Biotech hits a big six in CRC applications
26 June, 2002 by Pete YoungBiotechnology is making room for itself at the high table of Australia's scientific-industrial community, judging from the number of biotech-centric applications in the latest round of Cooperative Research Centre (CRC) funding.
